Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

ML Flow serological test: complementary tool in leprosy

Montanha JOM, Nardi SMT, Binhardi FMT, et al. Elsevier BV. Anais Brasileiros de Dermatologia. 2023;
Download PDF
Publication

Impacto da qPCR na avaliação diagnóstica de indivíduos com suspeição de hanseníase

Pinheiro MDS, Oliveira NGD, Santos DCMD, et al. Research, Society and Development. Research, Society and Development. 2023; 12 (3) : e13312340549.
Download PDF
Publication

Three-dimensional models of antigens with serodiagnostic potential for leprosy: An <i>in silico</i> study

Melo de Assis BL, Viana Vieira R, Rudenco Gomes Palma IT, et al. Baishideng Publishing Group Inc.. World Journal of Clinical Infectious Diseases. 2023; 13 (1) : 1-10.
Download PDF
Publication

Innovative Finance for Neglected Tropical Diseases: Discussion Paper

Global Institute for Disease Elimination. 2023;
Download PDF
Publication

Assessment of key regulatory genes and identification of possible drug targets for Leprosy (Hansen's disease) using network-based approach.

Khan M, Khan S, Lohani M, et al. Biotechnology & genetic engineering reviews. 2023;
Publication

Study of Correlation of High-Resolution Ultrasonography and Ultrasonography Guided Fine Needle Aspiration Cytology in Diagnosis of Pure Neuritic Leprosy in a Tertiary Care Hospital

Jena S, Panda S, Mohanty P, et al. Indian Journal of Leprosy. 2022;
Download PDF
Publication

Utility of a Mycobacterium leprae molecular viability assay for clinical leprosy: An analysis of cases from the Philippines, Ethiopia, and Nepal

Lenz SM, Ray NA, Lema T, et al. Frontiers Media SA. Frontiers in Tropical Diseases. 2022;
Download PDF
Publication

Role of molecular approaches to distinguish post kala-azar dermal leishmaniasis from leprosy: A case study

Roy S, Roy M, Nath S, et al. Scientific Scholar. Indian Journal of Dermatology, Venereology and Leprology. 2022;
Download PDF
Publication

Dermoscopy and clinicopathology features in diagnosing paucibacillary leprosy: Case series

Rusmawardiana R, Nursyarifah N, Argentina F, et al. Medknow. International Journal of Mycobacteriology. 2022; 11 (3) : 332.
Download PDF
Publication

Slit-skin smear for the classification of leprosy; are we wasting time and resource?

Demsiss W, van Henten S, Takarinda K, et al. Journal of infection in developing countries. 2022; 16 (8.1) : 3S-7S.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 17
  • Next page ››
Subscribe to Diagnostic tests

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD